CompanyGraphAt a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- FinancialsAltman Z-Score 10.76: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.14%
Annual Rate
CNY 0.15Paid annual
Payout Ratio
30.3%Sustainable
Payback Period
85.9 yr
Last Ex-Dividend
Jun 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.68BCNY694.78M · vs all stocks (USD)
Trailing P/E
39.76xRevenue (TTM)
827.65MCNY122.92M · vs all stocks (USD)
Profit Margin
14.36%Beta
0.5240xvs all stocks
52-Week Change
-14.01%vs all stocks
Market Capitalization
4.68BCNY694.78M · vs all stocks (USD)
Enterprise Value
3.94BCNY585.73M · vs all stocks (USD)
Trailing P/E
39.76xPrice to Sales (TTM)
5.65xPrice to Book (MRQ)
2.83xEnterprise to Revenue
4.76xEnterprise to EBITDA
32.20xGross Margin
57.78%Profit Margin
14.36%Operating Margin
24.26%Return on Assets (TTM)
2.90%Return on Equity (TTM)
6.97%Revenue (TTM)
827.65MCNY122.92M · vs all stocks (USD)
Revenue per Share (TTM)
2.30CNYUpdated Aug 20, 2026Quarterly Revenue Growth
17.00%Gross Profit (TTM)
428.77MCNY63.68M · vs all stocks (USD)
EBITDA (TTM)
143.30MCNY21.28M · vs all stocks (USD)
Net Income (TTM)
118.86MCNY17.65M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
0.10%Operating Cash Flow (TTM)
171.71MCNY25.50M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
43.02MCNY6.39M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1500CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.14%vs all stocks
Payout Ratio
30.28%Minority Interest (Equity)
120.44MCNYFY2025 · Dec 31, 2025Revenue
781.63MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
382.22MCNYFY2025 · Dec 31, 2025Gross Profit
399.41MCNYFY2025 · Dec 31, 2025Operating Income
91.91MCNY13.65M · vs all stocks (USD)
Pre-tax Income
137.48MCNYFY2025 · Dec 31, 2025Income Tax Expense
16.44MCNYFY2025 · Dec 31, 2025Net Income
121.05MCNYFY2025 · Dec 31, 2025EBIT
137.54MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
143.30MCNYFY2025 · Dec 31, 2025Research & Development
26.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
163.18MCNYFY2025 · Dec 31, 2025Other Operating Expenses
6.95MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
9.22MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
56.74KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
359.97MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
359.97MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
121.05MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.26MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
140.48MCNYFY2025 · Dec 31, 2025Free Cash Flow
-55.84MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
274.56MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
121.05MCNYFY2025 · Dec 31, 2025Other Non-cash Items
914.32KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
19.48MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-958.62KCNYFY2025 · Dec 31, 2025Capital Expenditures
-196.32MCNYFY2025 · Dec 31, 2025Net Acquisitions
1.41MCNYFY2025 · Dec 31, 2025Other Investing Activity
148.22MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-46.69MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-35.55MCNYFY2025 · Dec 31, 2025Other Financing Charges
-37.31MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-72.86MCNYFY2025 · Dec 31, 2025Shares Outstanding
356.55MSharesUpdated Aug 20, 2026Float Shares
108.41MSharesUpdated Aug 20, 2026% Held by Insiders
71.16%vs all stocks
% Held by Institutions
0.70%vs all stocks
Total Cash (MRQ)
869.35MCNY129.12M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.45CNYUpdated Aug 20, 2026Total Debt (MRQ)
3.37MCNY500.18K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0019xCurrent Ratio (MRQ)
3.83xBook Value per Share (MRQ)
4.64CNYUpdated Aug 20, 2026Total Assets
2.02BCNY299.57M · vs all stocks (USD)
Total Current Assets
1.21BCNYFY2025 · Dec 31, 2025Total Liabilities
298.60MCNYFY2025 · Dec 31, 2025Total Non-current Assets
804.60MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
35.90MCNYFY2025 · Dec 31, 2025Total Current Liabilities
262.70MCNYFY2025 · Dec 31, 2025Cash
258.00MCNYFY2025 · Dec 31, 2025Cash Equivalents
31.40MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
289.40MCNYFY2025 · Dec 31, 2025Other Short-term Investments
542.28MCNYFY2025 · Dec 31, 2025Accounts Receivable
24.31MCNYFY2025 · Dec 31, 2025Inventory
103.83MCNYFY2025 · Dec 31, 2025Accounts Payable
68.23MCNYFY2025 · Dec 31, 2025Short-term Debt
1.67MCNYFY2025 · Dec 31, 2025Other Current Liabilities
6.27MCNYFY2025 · Dec 31, 2025Long-term Debt
1.12MCNYFY2025 · Dec 31, 2025Common Stock (Book)
356.55MCNYFY2025 · Dec 31, 2025Retained Earnings
262.49MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.72BCNY255.22M · vs all stocks (USD)
Treasury Stock
15.24MCNYFY2025 · Dec 31, 202552-Week Low
11.40CNYUpdated Aug 20, 202652-Week High
19.25CNYUpdated Aug 20, 202652-Week Change
-14.01%vs all stocks
Beta
0.5240xvs all stocks
50-Day MA
12.36CNYUpdated Aug 20, 2026200-Day MA
14.38CNYUpdated Aug 20, 2026Avg 10-Day Volume
5.07MSharesUpdated Aug 20, 2026Avg 30-Day Volume
4.33MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.3300CNYUpdated Aug 20, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 10.76: safe zoneNotable
Altman Z-Score: 10.76
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Ars Pharmaceuticals Inc
Tier 1ProductionApproval-Gated PipelineRule
Revenio Group Oyj
Tier 1ProductionApproval-Gated PipelineRule
Shandong Keyuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Fuan Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Knight Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Omeros Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beijing Science Sun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Vishee Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
BridgeBio Oncology Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Obio Technology (Shanghai) Corp., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Hebei Keli Automobile Equipment Co., Ltd.
2 interpretationsCash Backing With Revenue And Income StreaksPrice Below Mean With Profitability And Book Value
Argosy Research Inc.
2 interpretationsCash Backing With Revenue And Income StreaksPrice Below Mean With Profitability And Book Value
Jiangsu Maysta Chemical Co., Ltd.
2 interpretationsCash Backing With Revenue And Income StreaksPrice Below Mean With Profitability And Book Value